Cargando…
Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study
The worldwide health emergency of the SARS-CoV-2 pandemic and the absence of a specific treatment for this new coronavirus have led to the use of computational strategies (drug repositioning) to search for treatments. The aim of this work is to identify FDA (Food and Drug Administration)-approved dr...
Autores principales: | Ramírez-Salinas, Gema Lizbeth, Martínez-Archundia, Marlet, Correa-Basurto, José, García-Machorro, Jazmín |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731341/ https://www.ncbi.nlm.nih.gov/pubmed/33260370 http://dx.doi.org/10.3390/molecules25235615 |
Ejemplares similares
-
In Silico Screening of Drugs That Target Different Forms of E Protein for Potential Treatment of COVID-19
por: Ramírez Salinas, Gema Lizbeth, et al.
Publicado: (2023) -
The Advantage of Using Immunoinformatic Tools on Vaccine Design and Development for Coronavirus
por: García-Machorro, Jazmín, et al.
Publicado: (2022) -
In Silico Drug Repositioning to Target the SARS-CoV-2 Main Protease as Covalent Inhibitors Employing a Combined Structure-Based Virtual Screening Strategy of Pharmacophore Models and Covalent Docking
por: Vázquez-Mendoza, Luis Heriberto, et al.
Publicado: (2022) -
In Vitro Analysis of SARS-CoV-2 Spike Protein and Ivermectin Interaction
por: García-Aguilar, Alejandra, et al.
Publicado: (2023) -
Inhibition of Influenza A Virus Infection In Vitro by Peptides Designed In Silico
por: López-Martínez, Rogelio, et al.
Publicado: (2013)